Summary
Chondroitin sulfate was administered orally to six healthy volunteers, six patients with rheumatoid arthritis and six patients with osteoarthritis. Blood was collected at intervals before and after treatment and the glycosaminoglycan concentration was analyzed in serum using a sensitive assay based on the metachromatic reaction with 1,9-dimethylmethylene blue. The glycosaminoglycan concentration in serum before and after ingestion of chondroitin sulfate was statistically unchanged in all of the subjects studied. We suggest that chondroprotection by orally administered chondroitin sulfate is a biologically and pharmacologically unfounded theory. Any possible benefit to osteoarthritic patients after ingestion of chondroitin sulfate should be sought at the gastrointestinal rather than at the plasmatic or articular cartilage level.
Similar content being viewed by others
References
Pipitone VR (1991) Chondroprotection with chondroitin sulfate. Drugs Exp Clin Res 17:3–7
Paroli E, Antonilli L, Biffoni M (1991) A pharmacological approach to glycosaminoglycans. Drugs Exp Clin Res 17:9–19
Fioravanti A, Franci A, Anselmi F, Fattorini L, Marcolongo R (1991) Clinical efficacy and tolerance of galactosoaminoglucuronoglycan sulfate in the treatment of osteoarthritis. Drugs Exp Clin Res 17:41–44
Oliviero U, Sorrentino GP, De Paola P, Tranfaglia E, D'Alessandro A, Carifi S, Porfido FA, Cerio R, Grasso AM, Policicchio D, Di Grezia F, Sorrentino P, Lingetti M (1991) Effects of the treatment with matrix on elderly people with chronic articular degeneration. Drugs Exp Clin Res 17:45–51
Rovetta G (1991) Galactosaminoglycuronoglycan sulfate (Matrix) in therapy of tibiofibular osteoarthritis of the knee. Drugs Exp Clin Res 17:53–57
Soldani G, Romagnoli J (1991) Experimental and clinical pharmacology of glycosaminoglycans. Drugs Exp Clin Res 17:81–85
Palmieri L, Conte A, Giovannini L, Lualdi P, Ronca G (1990) Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arzneimittelforschung/Drug Res 40:319–323
Conte A, Palmieri L, Segnini D, Ronca G (1991) Metabolic fate of partially depolymerized chondroitin sulfate administered to the rat. Drugs Exp Clin Res 17:27–33
Conte A, de Bernardi M, Palmieri L, Lualdi P, Mautone G, Ronca G (1991) Metabolic fate of exogenous chondroitin sulfate in man. Arzneimittelforschung/Drug Res 41:768–772
Dohlman CH (1956) The fate of the sulfate group of chondroitin sulfate after administration to rats. Acta Physiol Scand 37:220–234
Andermann G, Dietz M (1982) The influence of the route of administration on the bioavailability of an endogenous macro-molecule: chondroitin sulfate (CSA). Eur J Drug Metab Pharmacokinet 7:11–16
Konador A, Kawiak J (1977) Changes in chondroitin sulfate concentration in rabbit blood plasma depending on the method of its administration. Arch Immunol Ther Exp (Warsz) 25:895–903
Konador A, Kawiak J (1976) Distribution of radioactivity in the mouse organism after administration of 35S-chondroitin sulphate. Folia Biol (Krakow) 24:177–190
Dziewiatkowski DD (1956) Some aspects of the metabolism of chondroitin sulfate-35S in the rat. J Biol Chem 223:239–249
Farndale RW, Buttle DJ, Barrett AJ (1986) Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883:173–177
International Union of Pure and Applied Chemistry, Analytical Chemistry Division (1976) Nomenclature, symbols, units and their usage in spectrochemical analysis-II. Data interpretation. Anal Chem 48:2294–2296
Cowman MK, Slahetka MF, Hittner DM, Kim J, Forino M, Gadelrab G (1984) Polyacrylamide-gel electrophoresis and Alcian Blue staining of sulphated glycosaminoglycan oligosaccharides. Biochem J 221:707–716
Baici A, Lang A (1990) Cathepsin B secretion by rabbit articular chondrocytes: modulation by cycloheximide and glycosaminoglycans. Cell Tissue Res 259:567–573
Hampson IN, Gallagher JT (1984) Separation of radiolabelled glycosaminoglycan oligosaccharides by polyacrylamide-gel electrophoresis. Biochem J 221:697–705
Templeton DM (1988) The basis and applicability of the dimethylmethylene blue binding assay for sulfated glycosaminoglycans. Connect Tissue Res 17:23–32
Kantor TG, Schubert M (1957) A method for the desulfation of chondroitin sulfate. J Am Chem Soc 79:152–153
Németh-Csóka M, Kajtár M, Kajtár J (1977) The role of sulphation of glycosaminoglycans in their structural and functional characteristics. Connect Tissue Res 5:1–6
Chasseaud LF, Fry BJ, Saggers VH, Sword IP, Hathway DE (1972) Studies on the possible absorption of a sulphated glycopeptide (GLPS) in relation to its mode of action. Biochem Pharmacol 21:3121–3130
Bollet AJ, Seraydarian MW, Simpson WF (1957) Acid mucopolysaccharides in normal serum. J Clin Invest 36:1328–1332
Staprans I, Felts JM (1985) Isolation and characterization of glycosaminoglycans in human plasma. J Clin Invest 76:1984–1991
Bower L, Braven J, Manley G (1988) The isolation and characterization of glycosaminoglycans in normal human serum. J Pharm Biomed Anal 6:67–74
Juvani M, Friman C, Ranta H, Wegelius O (1975) Isolation and characterization of undersulfated chondroitin-4-sulphate from normal human plasma. Biochim Biophys Acta 411:1–10
Wood KM, Wusteman FS, Curtis CG (1973) The degradation of intravenously injected chondroitin 4-sulphate in the rat. Biochem J 134:1009–1013
Wood KM, Curtis CG, Powell GM, Wusteman FS (1973) The metabolic fate of chondroitin 4-[35S]sulphate in the rat. Biochem Soc Trans 1:840–842
Revell PA, Muir H (1972) The excretion and degradation of chondroitin 4-sulphate administered to guinea pigs as free chondroitin sulphate and as proteoglycan. Biochem J 130:597–606
Kaplan D, Meyer K (1962) The fate of injected mucopolysaccharides. J Clin Invest 41:743–749
Buermann CW, Oronsky AL, Horowitz MI (1979) Chondroitin sulfate-degrading enzymes in human polymorphonuclear leukocytes: characteristics and evidence for concerted mechanisms. Arch Biochem Biophys 193:277–283
Salkie ML (1971) The acid glycosaminoglycan-degrading activity of normal human serum. Clin Chim Acta 31:300–302
Fishman WH, Kato K, Anstiss CL, Green S (1967) Human serum β-glucuronidase; its measurement and some of its properties. Clin Chim Acta 15:435–447
Niebes P, Schifflers MH (1975) Micromethod for the determination of glycosaminoglycans in the serum. Results from the serum of healthy and varicose subjects. Clin Chim Acta 62:195–202
Larking PW (1989) Total glycosaminoglycans in the plasma of adults: effects of age and gender, and relationship to plasma lipids: a preliminary study. Biochem Med Metab Biol 42:192–197
Toyoda H, Yamanashi S, Hakamada Y, Shinomiya K, Imanari T (1989) Profile analysis of chondroitin sulfates in human urine and serum. Chem Pharm Bull (Tokyo) 37:1627–1628
Wilson TH (1962) Intestinal absorption. Saunders, Philadelphia London, Chapter 3
Schanker LS, Tocco DJ, Brodie BB, Hogben CAM (1958) Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther 123:81–88
Fischer A, Astrup T (1939) On the administration of heparin per os. Proc Soc Exp Biol Med 42:81–82
Loomis TA (1959) Absorption of heparin from the intestine. Proc Soc Exp Biol Med 101:447–449
Salafsky B, Loomis TA (1960) Intestinal absorption of a modified heparin. Proc Soc Exp Biol Med 104:62–65
Windsor E, Cronheim GE (1961) Gastro-intestinal absorption of heparin and synthetic heparinoids. Nature 190:263–264
Engel RH, Riggi SJ (1969) Intestinal absorption of heparin: a study of the interactions of components of oil-in-water emulsions. J Pharm Sci 58:1372–1375
Engel RH, Fahrenbach MJ (1968) Intestinal absorption of heparin in the rat and gerbil. Proc Soc Exp Biol Med 129:772–777
Engel RH, Riggi SJ (1969) Effect of sulfated and sulfonated surfactants on the intestinal absorption of heparin. Proc Soc Exp Biol Med 130:879–884
Liau YH, Galicki N, Horowitz MI (1981) Degradation of chondroitin 4-sulfate by rat stomach exoglycosidases, sulfohydrolase and hyaluronidase-like enzymes. Digestion 21:117–124
Liau YH, Horowitz MI (1974) Desulfation and depolymerization of chondroitin 4-sulfate and its degradation products by rat stomach, liver and small intestine. Proc Soc Exp Biol Med 146:1037–1043
Liau YH, Horowitz MI (1973) Desulfation of sulfated polyanions by rat gastric mucosa. Proc Soc Exp Biol Med 144:13–16
Liau YH, Galicki NI, Horowitz MI (1978) Heterogeneity of rat rib chondroitin sulfate and susceptibility to rat gastric chondrosulfatase. Biochim Biophys Acta 539:315–323
Segre G (1986) Aspetti farmacologici dei glucosaminoglicani. Minerva Med 77:1859–1864
Baici A, Bradamante P (1984) Interaction between human leukocyte elastase and chondroitin sulfate. Chem Biol Interact 51:1–11
Avila JL, Convit J (1976) Physicochemical characteristics of the glycosaminoglycan-lysosomal enzyme interaction in vitro. A model of control of leucocytic lysosomal activity. Biochem J 160:129–136
Navia MA, McKeever BM, Springer JP, Lin TY, Williams HR, Fluder EM, Dorn CP, Hoogsteen K (1989) Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-Å resolution. Proc Natl Acad Sci USA 86:7–11
Baici A (1990) Properties of inhibitors of extracellular matrix-degrading endopeptidases in rheumatic diseases. Habilitationsschrift, University of Zurich, pp 145–154
Crivelli E, Voy ED (1987) Arthrose des grandes articulations. Étude de phase IV sur l'action de doses orales de sulfate de chondroïtine chez 255 patients. Der Informierte Arzt 8:78–82
Langman MJS (1991) Peptic ulcers and non-steroidal anti-inflammatory drugs. Eur J Rheumatol Inflamm 11:13–18
Prino G, Lietti A, Paglialunga S (1971) Inhibition of gastric peptic activity by a new sulfate glycopeptide (GLPS). Arzneimittelforschung/Drug Res 21:918–921
Prino G, Paglialunga S, Nardi G, Lietti A (1971) Inhibition of experimentally-induced gastric ulcers in the rat by a new sulfated glycopeptide. Eur J Pharmacol 15:119–126
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baici, A., Hörler, D., Moser, B. et al. Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate. Rheumatol Int 12, 81–88 (1992). https://doi.org/10.1007/BF00290259
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00290259